Literature DB >> 10672126

Epidemics of vascular toxicity and pulmonary hypertension: what can be learned?

P Egermayer1.   

Abstract

Epidemics of vascular disease caused by toxins and infectious agents affecting both humans and animals have been common in history. Examples of agents implicated include anorexients, ergotamine, mercury, arsenic, vinyl chloride, thorotrast, plant alkaloids, nitrites, toxic oil, tryptophan and bacterial, viral and parasitic infections. A major characteristic of these disorders is endothelial dysfunction, which may manifest itself in vasospastic disorders, sclerodermiform skin lesions, fibrosis, osteolytic lesions, polyneuropathy and portal and pulmonary hypertension. Angiosarcoma may also be a late outcome. These diseases are more common than is generally appreciated. The aetiology is usually multifactorial. This and other factors contribute to delayed recognition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672126     DOI: 10.1046/j.1365-2796.2000.00586.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  4 in total

1.  Noncirrhotic intrahepatic portal hypertension: towards a unifying definition and etiology.

Authors:  B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2014-05-31

2.  Ultrasensitive determination of mercury ions using a glassy carbon electrode modified with nanocomposites consisting of conductive polymer and amino-functionalized graphene quantum dots.

Authors:  Bowen Tian; Yanxia Kou; Xiangmei Jiang; Jiajia Lu; Yuanyuan Xue; Meijuan Wang; Liang Tan
Journal:  Mikrochim Acta       Date:  2020-03-09       Impact factor: 5.833

3.  Modulation of vasodilator response via the nitric oxide pathway after acute methyl mercury chloride exposure in rats.

Authors:  S Omanwar; B Saidullah; K Ravi; M Fahim
Journal:  Biomed Res Int       Date:  2013-08-19       Impact factor: 3.411

4.  Natural plant products in treatment of pulmonary arterial hypertension.

Authors:  Lili Xiang; Ying Li; Xu Deng; Djuro Kosanovic; Ralph Theo Schermuly; Xiaohui Li
Journal:  Pulm Circ       Date:  2018-06-05       Impact factor: 3.017

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.